Meta AnalysisID 6054

中药方剂灯盏生脉胶囊治疗痴呆的临床疗效:系统评价与Meta分析方案

CRD42022381027

Is Dengzhan Shengmai Capsule(I) effective in the treatment of dementia(P)? Is Dengzhan Shengmai Capsule as useful or more useful than conventional therapy(C)?

Back to Browse

Relationship Network

Interactive first-hop connections across herbs, ingredients, formulas, targets, diseases, symptoms, syndromes, evidence, and monographs.

Click a node to open it in a new tab
Formula: 1Meta-analysis: 1Links: 1
Arranging relationship network...

Record Fields

Scalar fields from the final meta_analysis record.

Meta Analysis Id
6054
Evidence Id
14612
Core Evidence Id
14612
Source Meta Analysis Id
6037
Herb2 Meta Analysis Id
HBMA006037
Crd Id
CRD42022381027
Title
Clinical therapeutic efficacy of Traditional Chinese Medicine Formula Dengzhan Shengmai capsule in dementia: A protocol for systematic review and meta-analysis
Review Question
Is Dengzhan Shengmai Capsule(I) effective in the treatment of dementia(P)? Is Dengzhan Shengmai Capsule as useful or more useful than conventional therapy(C)?
Study Type Included
RCT
Condition Being Studied
Dementia is a disease in which memory, thought, and behavior-related disorders progress gradually due to brain damage caused by injury or disease. It is mainly caused by Alzheimer’s disease or vascular dementia and several other risk factors, including genetic factors. Nearly 47.5 million people worldwide have dementia.The challenge to families and health and socialservices is substantial.At present, the treatment of Dementia uses drugs. Western medicine mostly takes drugs such as cholinesterase inhibitors and NMDA receptor antagonists to treat dementia, but the overall effect is not ideal due to the complicated pathogenesis of Dementia. Traditional Chinese medicine(TCM) has made up for the deficiency and limitation of western medicine treatments on Dementia through holistic, comprehensive and dynamic methods. In recent years, Dengzhan Shengmai Capsule has been studied in the treatment of AD.However, the efficacy of Dengzhan Shengmai Capsule have not yet reached a definitive conclusion. Therefore, this research is designed to evaluate the efficacy of the Dengzhan Shengmai Capsule for Dementia using the method of systematic review and meta-analysis.
Participant
The participants should meet the criteria for dementia as defined by the Diagnostic and Statistical Manual of Mental Disorders (4th edition), regardless of their degree and possible complications. There is no limitation in their genders, races and regions.
Animal
Human Disease Modelled
Intervention
All treatment modality performed of Dengzhan Shengmai Capsules in dementia will be considered as interventions.
Comparator Control
The control group received conventional western medicine treatment.
Main Outcome
1.The cognitive function of dementia was measured by the Simple Intelligence Mental State Scale (MMSE), Montreal Cognitive Assessment Scale (MoCA). 2.The ability to take care of oneself in daily life in dementia was measured by the Ability to Perform Daily Living Scale (ADL).
Outcome Measure
Additional Outcome
Endothelin-1 (ET-1), nitric oxide (NO)
Study Method
Systematic review, Other
Keyword
Dementia; Humans; Medicine, Chinese Traditional; Meta-Analysis as Topic; Systematic Reviews as Topic; fructus schizandrae, radix ginseng, radix ophiopogonis drug combination
Contact
Qianfeng Shao [email protected]
Organisational Affiliation
Guangzhou University of Traditional Chinese Medicine, Fourth School of Clinical Medicine, China
Funding Source
Other Selection Criteria
Final Publication
Same Topic Review
Published Protocol
Review Type
Language
English
Country
China
Review Stage
Review Ongoing
First Submission Date
2022-12-02
Registration Date
2022-12-13
Anticipated Start Date
2022-12-02
Anticipated Completion Date
2023-01-01
Title Cn
中药方剂灯盏生脉胶囊治疗痴呆的临床疗效:系统评价与Meta分析方案
Title En
Clinical therapeutic efficacy of Traditional Chinese Medicine Formula Dengzhan Shengmai capsule in dementia: A protocol for systematic review and meta-analysis
Bilingual Status
complete